This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2015 May 28;372(22):2127-35.

doi: 10.1056/NEJMra1405427.

Latent Mycobacterium tuberculosis infection

Haileyesus Getahun, Alberto Matteelli, Richard E Chaisson, Mario Raviglione

PMID: 26017823
DOI: 10.1056/NEJMra1405427

Review

Latent Mycobacterium tuberculosis infection

Haileyesus Getahun et al. N Engl J Med. 2015.

. 2015 May 28;372(22):2127-35.

doi: 10.1056/NEJMra1405427.

Authors

Haileyesus Getahun, Alberto Matteelli, Richard E Chaisson, Mario Raviglione

PMID: 26017823
DOI: 10.1056/NEJMra1405427

No abstract available

PubMed Disclaimer

Comment in

Latent Mycobacterium tuberculosis Infection.
Getahun H, Chaisson RE, Raviglione M. Getahun H, et al. N Engl J Med. 2015 Sep 17;373(12):1179-80. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376149 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Jones JG, King TC. Jones JG, et al. N Engl J Med. 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376150 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Ogbuagu O, Ogbuagu A. Ogbuagu O, et al. N Engl J Med. 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376151 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Tam JK. Tam JK. N Engl J Med. 2015 Sep 17;373(12):1178-9. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376152 No abstract available.
Latent Mycobacterium tuberculosis Infection.
Flood J, Scott J, Belknap R. Flood J, et al. N Engl J Med. 2015 Sep 17;373(12):1179. doi: 10.1056/NEJMc1508223. N Engl J Med. 2015. PMID: 26376153 No abstract available.

Similar articles

Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
Daskalaki I, Byun J, Dogbey MC, Tolbert-Warren C, Watson BM. Daskalaki I, et al. Pediatr Infect Dis J. 2011 Nov;30(11):1014-5. doi: 10.1097/INF.0b013e31823234c9. Pediatr Infect Dis J. 2011. PMID: 21997666 No abstract available.
Treatment of latent tuberculosis infection.
Parekh MJ, Schluger NW. Parekh MJ, et al. Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20. Ther Adv Respir Dis. 2013. PMID: 24056289 Review.
3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
Assefa Y, Assefa Y, Woldeyohannes S, Hamada Y, Getahun H. Assefa Y, et al. Eur Respir J. 2018 Jul 11;52(1):1800395. doi: 10.1183/13993003.00395-2018. Print 2018 Jul. Eur Respir J. 2018. PMID: 29748305 Free PMC article.
Three months of once-weekly isoniazid plus rifapentine (3HP) in treating latent tuberculosis infection is feasible in patients with rheumatoid arthritis.
Chen YM, Liao TL, Chen HH, Chen DY. Chen YM, et al. Ann Rheum Dis. 2018 Nov;77(11):1688-1689. doi: 10.1136/annrheumdis-2018-213097. Epub 2018 Apr 19. Ann Rheum Dis. 2018. PMID: 29674320 No abstract available.
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan.
Sun HY, Huang YW, Huang WC, Chang LY, Chan PC, Chuang YC, Ruan SY, Wang JY, Wang JT. Sun HY, et al. Tuberculosis (Edinb). 2018 Jul;111:121-126. doi: 10.1016/j.tube.2018.05.013. Epub 2018 Jun 7. Tuberculosis (Edinb). 2018. PMID: 30029896 Clinical Trial.

See all similar articles

Cited by

Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.
Corbett C, Kulzhabaeva A, Toichkina T, Kalmambetova G, Ahmedov S, Antonenka U, Iskakova A, Kosimova D, Migunov D, Myrzaliev B, Sahalchyk E, Umetalieva N, Vogel M, Kadyrov A, Hoffmann H. Corbett C, et al. BMC Infect Dis. 2020 Oct 12;20(1):746. doi: 10.1186/s12879-020-05465-x. BMC Infect Dis. 2020. PMID: 33046016 Free PMC article.
Changes in immune status of circulating NK cells in patients with latent tuberculosis infection.
Qin S, Chen R, Li M, Lv J, Zhang F, Ren Y, Lin X. Qin S, et al. Cent Eur J Immunol. 2024;49(2):105-112. doi: 10.5114/ceji.2024.142104. Epub 2024 Aug 12. Cent Eur J Immunol. 2024. PMID: 39381552 Free PMC article.
Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children.
Yun KW, Kim YK, Kim HR, Lee MK, Lim IS. Yun KW, et al. Korean J Pediatr. 2016 Jun;59(6):256-61. doi: 10.3345/kjp.2016.59.6.256. Epub 2016 Jun 30. Korean J Pediatr. 2016. PMID: 27462354 Free PMC article.
The puzzle of the evolutionary natural history of tuberculosis.
Fellag M, Loukil A, Drancourt M. Fellag M, et al. New Microbes New Infect. 2020 Aug 1;41:100712. doi: 10.1016/j.nmni.2020.100712. eCollection 2021 May. New Microbes New Infect. 2020. PMID: 33996102 Free PMC article. Review.
The Study of Associated Factors for Non-Tuberculous Mycobacterial Pulmonary Disease Compared to Pulmonary Tuberculosis: A Propensity Score Matching Analysis.
Zhang W, Liu H, Li T, Jiang Y, Cao X, Chen L, Zhou L. Zhang W, et al. Infect Drug Resist. 2024 Jul 23;17:3189-3197. doi: 10.2147/IDR.S467257. eCollection 2024. Infect Drug Resist. 2024. PMID: 39070718 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

P30 AI094189/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov